Home » Topics » BioWorld MedTech

BioWorld MedTech
RSS

PERSEPTIVE RAISES $6.75M IN FUNDING

Aug. 21, 1991

COLUMBIA RAISES $15 MILLION

Aug. 21, 1991

VIMRX SHIPS AIDS TREATMENT TO NIH

Aug. 21, 1991

APPLIED IMAGING BUYS DIVISION OF BRITISH FIRM

Aug. 21, 1991

BIOTECHNICA LICENSES MGI's CORN GENE

Aug. 21, 1991

BTGC CLOSE TO WIPING OUT DEBT

Aug. 20, 1991

BIOGROWTH GETS SBIR FOR LEANER MEAT

Aug. 20, 1991

INCSTAR TO SELL CELLULAR'S AIDS TEST

Aug. 20, 1991

ICN SUBMITS NDA FOR ANTI-VIRAL

Aug. 20, 1991

CELTRIX UNDERWRITERS EXERCISE OPTION

Aug. 20, 1991

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 8, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 7, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld Science
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Development and characterization of anti-CD19 in vivo CAR T therapy
BioWorld Science
Shenzhen Grit Biotechnology Co. Ltd. and Shanghai Vitalgen Biopharma Co. Ltd. recently presented their work to develop and evaluate a novel anti-CD19 in vivo CAR...
Science in 2025: the best of the rest
BioWorld Science
A review of 2025's noteworthy advances in medical research, including GLP-1 receptor agonists as anti-aging drugs, tumor-agnostic therapies and xenotransplants.